DNAprint Genomics (DNAG)

[Gcbr]

fud I will post this for you one more time.

"With this technology, pharmaco-genomics, it allows us to take a sample of DNA from any patient and in the lab predict response - who is going to respond well, who will have side effects. Obviously, we can do that then by maximizing the efficiency of the drugs and minimizing the side effects, based on the person's genetic makeup," Gomez said.

Both Gomez and DNAPrint Genomics will also be part of a massive research initiative announced last month by the H. Lee Moffitt Cancer Center & Research Institute of Tampa. The center said it would partner with an affiliate of Merck & Co., Inc. pharmaceutical company to expand biotechnology research with the goal of developing personalized medicine.

Merck and Moffitt will form a for-profit company, called M2GEN, that will develop personalized cancer treatments using a patient's genetic profile.

http://www.bradenton.com/mld/bradenton/business/16502822.htm